Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Rudick

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
Archives of Neurology|March 1, 1992
Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activityR A Rudick, R M Ransohoff
CNS Drugs|January 23, 2013
Prescribing recommendations for interferon-Beta in multiple sclerosisB Weinstock-Guttman, R A Rudick
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2002
The multiple sclerosis functional composite: a new clinical outcome measure for multiple sderosis trialsR A Rudick, G Cutter, S Reingold
Archives of Neurology|October 1, 1987
The GABA-agonist progabide for spasticity in multiple sclerosisR A Rudick, D Breton, R L Krall
Archives of Neurology|October 1, 1989
Exacerbation rates and adherence to disease type in a prospectively followed-up population with multiple sclerosis. Implications for clinical trialsD E Goodkin, D Hertsgaard, R A Rudick
Neurology|August 1, 1987
Free light chains in multiple sclerosis and infections of the CNSC DeCarli, M A Menegus, R A Rudick
Cleveland Clinic Journal of Medicine|January 1, 1992
Experimental therapies for multiple sclerosis: current statusD E Goodkin, R M Ransohoff, R A Rudick
Cleveland Clinic Journal of Medicine|May 1, 1992
Pharmacotherapy of multiple sclerosis: current statusR A Rudick, D E Goodkin, R M Ransohoff
Archives of Neurology|May 1, 1994
The use of brain magnetic resonance imaging in multiple sclerosisD E Goodkin, R A Rudick, J S Ross
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2007
Optimal reference population for the multiple sclerosis functional compositeR J Fox, J-C Lee, R A Rudick
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Archives of Neurology|March 1, 1992
Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activityR A Rudick, R M Ransohoff
CNS Drugs|January 23, 2013
Prescribing recommendations for interferon-Beta in multiple sclerosisB Weinstock-Guttman, R A Rudick
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2002
The multiple sclerosis functional composite: a new clinical outcome measure for multiple sderosis trialsR A Rudick, G Cutter, S Reingold
Archives of Neurology|October 1, 1987
The GABA-agonist progabide for spasticity in multiple sclerosisR A Rudick, D Breton, R L Krall
Archives of Neurology|October 1, 1989
Exacerbation rates and adherence to disease type in a prospectively followed-up population with multiple sclerosis. Implications for clinical trialsD E Goodkin, D Hertsgaard, R A Rudick
Neurology|August 1, 1987
Free light chains in multiple sclerosis and infections of the CNSC DeCarli, M A Menegus, R A Rudick
Cleveland Clinic Journal of Medicine|January 1, 1992
Experimental therapies for multiple sclerosis: current statusD E Goodkin, R M Ransohoff, R A Rudick
Cleveland Clinic Journal of Medicine|May 1, 1992
Pharmacotherapy of multiple sclerosis: current statusR A Rudick, D E Goodkin, R M Ransohoff
Archives of Neurology|May 1, 1994
The use of brain magnetic resonance imaging in multiple sclerosisD E Goodkin, R A Rudick, J S Ross
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2007
Optimal reference population for the multiple sclerosis functional compositeR J Fox, J-C Lee, R A Rudick
Pageof 13